RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
70 hedge funds and large institutions have $89.1M invested in Regulus Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7.03% less ownership
Funds ownership: 93.68% → 86.65% (-7%)
19% less capital invested
Capital invested by funds: $109M → $89.1M (-$20.4M)
Holders
70
Holding in Top 10
1
Calls
$195K
Puts
$87K
Top Buyers
| 1 | +$3.35M | |
| 2 | +$1.4M | |
| 3 | +$510K | |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$486K |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$204K |
Top Sellers
| 1 | -$8.61M | |
| 2 | -$2.66M | |
| 3 | -$1.48M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$588K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$446K |